Shawn Egan

Stock Analyst at Citigroup

(1.99)
# 3,130
Out of 5,090 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $61.44
Upside: -72.33%